Merits of new cholesterol-lowering drug overstated in some media reporting

Health Headlines Commentary for March 20, 2017

Source:

Cholesterol drug prevents heart attacks — but costs $14K a year

Reference:

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Bitnami